bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeq™, an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections.
World leader in microbiology launches educational campaign focused on antibiotic resistance
New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology
MARCY L'ETOILE – October 22, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2015.
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform
From U.S. News & World Report: Sepsis is responsible for 250,000 deaths a year in the U.S., mostly because treatment isn't given in time.
Event to be held in Washington D.C. and will feature Sen. Charles E. Schumer (D-NY) and Families from around the nation who have been impacted by sepsis.
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on August 28 under the chairmanship of Jean-Luc Belingard and approved the consolidated financial statements for the six months ended June 30, 2015. The Statutory Auditors had performed a review of the financial statements.
Global healthcare leader educates public about sepsis dangers through Strike Out Sepsis events, webinars, grand rounds and Faces of Sepsis survivor stories during Sepsis Awareness Month
